Centennial Wealth Advisory Builds Stake in First Trust Growth Strength ETF, According to Recent SEC Filing

Centennial Wealth Advisory LLC increased its FTGS position by 91,927 shares in Q1, bringing holdings to 216,767 shares valued at $7.38 million. The purchase represented 1.79% of reportable AUM and lifted the position value by $2.97 million quarter over quarter, but FTGS remained outside the fund’s top five holdings. The article is primarily a holdings update with limited expected price impact.

Analysis

This is not a high-conviction directional signal on FTGS; it’s a modest allocator-size increase that tells us more about portfolio construction than about a macro view on growth. Centennial is adding to a liquid beta sleeve, likely to keep growth exposure in line after recent factor drift, which means the marginal buyer is probably systematic rebalancing rather than a fundamental call on the ETF’s edge. The second-order read is that advisors still want growth exposure, but they want it through a rules-based wrapper that dampens single-name blowups and reduces career risk versus owning the concentrated mega-cap growth basket outright.

The competitive dynamic matters more in the underlying constituents than in FTGS itself. If growth leadership broadens beyond the usual momentum names, funds like this can quietly outperform because they underwrite earnings quality and balance-sheet strength rather than pure duration; if leadership narrows to high-beta AI/consumer platforms, FTGS will likely lag a more concentrated basket. That creates an interesting relative-value setup: this ETF is a lower-octane proxy for growth, so flows into it can be interpreted as investors paying up for participation without wanting full exposure to speculative factor volatility.

The contrarian point is that the headline looks like endorsement, but the scale suggests no urgency and no informational edge about the next leg in growth. In practice, these incremental adds often occur after a prior move has already happened, which can make them lagging rather than leading indicators. If rates back up or earnings revisions roll over in the next 1-3 months, the fund’s quality tilt should help on the downside, but it will not protect against a broad de-rating in growth multiples.

Key Decisions for Investors

• Use FTGS only as a tactical beta sleeve, not a core growth expression: buy on a 2-3% pullback or after a short-term rates selloff, with a 4-6 week holding period and a tight stop if the growth factor underperforms broad market by >2% over 10 trading days.
• Prefer a pair trade: long FTGS / short a higher-duration growth proxy (e.g. ARKK) for 1-3 months. Risk/reward favors the long quality-growth basket if rates stay volatile and speculative growth de-rates.
• If you want direct single-name upside, bypass FTGS and own NFLX/NVDA on earnings pullbacks; FTGS dilutes idiosyncratic upside and is unlikely to capture the full re-acceleration if AI and platform leadership resumes.
• For risk-off hedging, pair FTGS against a small short in equal-weight growth-heavy benchmarks rather than the S&P; the ETF should hold up better in a quality rotation, but underperform if momentum leadership returns abruptly.